BCL2L11 and non-small cell lung carcinoma: Bim, a pro-apoptotic factor mutated in non-small cell lung cancer (NSCLC)11–13, Leukemia14,15 and Neuroblastomas16, is regulated at the level of splicing, phosphorylation, localization and protein turnover17.